Lead Product(s) : Vitamin B1
Therapeutic Area : Neurology
Study Phase : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Alzheimer's Pill Begins Trials at 50 Centers Across the U.S.
Details : Benfotiamine is a synthetic version of vitamin B1 (thiamine), which is being evaluated as a treatment for mild cognitive impairment and early Alzheimer's disease.
Product Name : Benfotiamine
Product Type : Miscellaneous
Upfront Cash : Inapplicable
September 23, 2024
Lead Product(s) : Vitamin B1
Therapeutic Area : Neurology
Highest Development Status : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Vitamin B1
Therapeutic Area : Endocrinology
Study Phase : Phase I
Sponsor : Buck Institute for Research on Aging | University of Wyoming
Deal Size : Inapplicable
Deal Type : Inapplicable
Pilot Study of GLY-LOW Supplementation in Postmenopausal Women With Obesity
Details : Vitamin B1 is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Insulin Resistance.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 05, 2024
Lead Product(s) : Vitamin B1
Therapeutic Area : Endocrinology
Highest Development Status : Phase I
Sponsor : Buck Institute for Research on Aging | University of Wyoming
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Vitamin B1
Therapeutic Area : Neurology
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Vitamin B1 is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Peripheral Nervous System Diseases.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 16, 2022
Lead Product(s) : Vitamin B1
Therapeutic Area : Neurology
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Vitamin B1
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Thiamine, Vitamin C and Hydrocortisone in the Treatment of Septic Shock
Details : Thiamine is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in clinical studies for the treatment of Shock, Septic.
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
May 30, 2018
Lead Product(s) : Vitamin B1
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Vitamin B1
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase I
Sponsor : McMaster/St. Peter's Hospital Chair of Aging
Deal Size : Inapplicable
Deal Type : Inapplicable
Thiamine Supplementation in Heart Failure: a Pilot Randomized Controlled Crossover Trial
Details : Thiamine is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Heart Failure.
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
July 24, 2017
Lead Product(s) : Vitamin B1
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase I
Sponsor : McMaster/St. Peter's Hospital Chair of Aging
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Vitamin B1
Therapeutic Area : Neurology
Study Phase : Phase III
Sponsor : Bausch Health
Deal Size : Inapplicable
Deal Type : Inapplicable
Safety and Efficacy of Neuromultivit in Treatment of Vertebrogenic Radiculopathy
Details : Thiamine is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Radiculopathy.
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
July 27, 2015
Lead Product(s) : Vitamin B1
Therapeutic Area : Neurology
Highest Development Status : Phase III
Sponsor : Bausch Health
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Vitamin B1
Therapeutic Area : Nutrition and Weight Loss
Study Phase : Phase I
Sponsor : Eastern Mennonite Missions | Arup Laboratories
Deal Size : Inapplicable
Deal Type : Inapplicable
Pharmacokinetics of Thiamine in Breastfeeding Mothers and Infants
Details : Thiamine is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Beriberi.
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
May 29, 2013
Lead Product(s) : Vitamin B1
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Phase I
Sponsor : Eastern Mennonite Missions | Arup Laboratories
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
